Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Jun;3(3):510–512. doi: 10.1111/j.1365-2125.1976.tb00630.x

Factors affecting drug-protein binding in the plasma of newborn infants.

S Wallace
PMCID: PMC2958768  PMID: 973977

Full text

PDF
510

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campion D. S. Decreased drug binding by serum albumin during renal failure. Toxicol Appl Pharmacol. 1973 Jul;25(3):391–397. doi: 10.1016/0041-008x(73)90312-8. [DOI] [PubMed] [Google Scholar]
  2. Campion D. S., Olsen R. Measurement of drug displacement by continuous ultrafiltration. J Pharm Sci. 1974 Feb;63(2):249–252. doi: 10.1002/jps.2600630215. [DOI] [PubMed] [Google Scholar]
  3. Chignell C. F., Vesell E. S., Starkweather D. K., Berlin C. M. The binding of sulfaphenazole to fetal, neonatal, and adult human plasma albumin. Clin Pharmacol Ther. 1971 Nov-Dec;12(6):897–901. doi: 10.1002/cpt1971126897. [DOI] [PubMed] [Google Scholar]
  4. Ehrnebo M., Agurell S., Jalling B., Boréus L. O. Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. Eur J Clin Pharmacol. 1971 Sep;3(4):189–193. doi: 10.1007/BF00565004. [DOI] [PubMed] [Google Scholar]
  5. Ganshorn A., Kurz H. Unterschiede zwischen der Proteinbindung Neugeborener und Erwachsener und ihre Bedeutung für die pharmakologische Wirkung. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;260(2):117–118. [PubMed] [Google Scholar]
  6. Krasner J., Giacoia G. P., Yaffe S. J. Drug-protein binding in the newborn infant. Ann N Y Acad Sci. 1973 Nov 26;226:101–114. doi: 10.1111/j.1749-6632.1973.tb20473.x. [DOI] [PubMed] [Google Scholar]
  7. Mirkin B. L. Developmental pharmacology. Annu Rev Pharmacol. 1970;10:255–272. doi: 10.1146/annurev.pa.10.040170.001351. [DOI] [PubMed] [Google Scholar]
  8. Rane A., Lunde P. K., Jalling B., Yaffe S. J., Sjöqvist F. Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants. J Pediatr. 1971 May;78(5):877–882. doi: 10.1016/s0022-3476(71)80369-4. [DOI] [PubMed] [Google Scholar]
  9. TRINDER P. Rapid determination of salicylate in biological fluids. Biochem J. 1954 Jun;57(2):301–303. doi: 10.1042/bj0570301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Windorfer A., Kuenzer W., Urbanek R. The influence of age on the activity of acetylsalicylic acid-esterase and protein-salicylate binding. Eur J Clin Pharmacol. 1974;7(3):227–231. doi: 10.1007/BF00560385. [DOI] [PubMed] [Google Scholar]
  11. Yaffe S. J. Some aspects of perinatal pharmacology. Annu Rev Med. 1966;17:213–234. doi: 10.1146/annurev.me.17.020166.001241. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES